Dexcom warned users in May that two lots of its G7 continuous glucose monitoring sensors were stolen during a destruction process and subsequently sold by third parties. The company traced some of the resale activity to Pharmsource LLC, a drug wholesaler based in Brunswick, Georgia. Pharmsource stated it had zero involvement in Dexcom’s destruction process, immediately launched a full audit of its inventory, implemented remedial measures, and pledged to assist authorities in their investigation. Dexcom disclosed that one of the affected lots may carry an increased risk of skin infection, while the other lot has a higher likelihood of producing no glucose readings. The article was generated with AI support and reviewed by an editor.